| Paul Dominick Colavita, MD | |
|
1025 Morehead Medical Dr, Ste 300, Charlotte, NC 28204-2963 | |
| (704) 355-1813 | |
| Not Available |
| Full Name | Paul Dominick Colavita |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 15 Years |
| Location | 1025 Morehead Medical Dr, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053546861 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2016-01260 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Atrium Health Cleveland | Shelby, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Medical Center | 4789597477 | 735 |
News Archive
Contrary to previous research findings that have suggested a link, marijuana use does not appear to be associated with an increased risk of developing oral cancer, according to a large, population-based study led by researchers at Fred Hutchinson Cancer Research Center.
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
The use of meshed split skin autographs (SSGs) is a standard treatment for large, deep burns. However, serious scarring is often a result. In an effort to improve wound healing and reduce scarring, a team of researchers in The Netherlands tested a treatment technique on patients with serious, deep burns that employed SSGs along with autologous cultured proliferating epidermal cells (ECs) compared to SSGs alone.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a low uptake, partly because of concerns about how it will affect adolescent sexual activity.
› Verified 9 days ago
| Entity Name | Carolinas Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774333 PECOS PAC ID: 4789597477 Enrollment ID: O20031110000116 |
News Archive
Contrary to previous research findings that have suggested a link, marijuana use does not appear to be associated with an increased risk of developing oral cancer, according to a large, population-based study led by researchers at Fred Hutchinson Cancer Research Center.
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
The use of meshed split skin autographs (SSGs) is a standard treatment for large, deep burns. However, serious scarring is often a result. In an effort to improve wound healing and reduce scarring, a team of researchers in The Netherlands tested a treatment technique on patients with serious, deep burns that employed SSGs along with autologous cultured proliferating epidermal cells (ECs) compared to SSGs alone.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a low uptake, partly because of concerns about how it will affect adolescent sexual activity.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Dominick Colavita, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Paul Dominick Colavita, MD 1025 Morehead Medical Dr, Ste 300, Charlotte, NC 28204-2963 Ph: (704) 355-1813 |
News Archive
Contrary to previous research findings that have suggested a link, marijuana use does not appear to be associated with an increased risk of developing oral cancer, according to a large, population-based study led by researchers at Fred Hutchinson Cancer Research Center.
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
The use of meshed split skin autographs (SSGs) is a standard treatment for large, deep burns. However, serious scarring is often a result. In an effort to improve wound healing and reduce scarring, a team of researchers in The Netherlands tested a treatment technique on patients with serious, deep burns that employed SSGs along with autologous cultured proliferating epidermal cells (ECs) compared to SSGs alone.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a low uptake, partly because of concerns about how it will affect adolescent sexual activity.
› Verified 9 days ago
Dr. John Gordon Morrison, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2015 Randolph Rd, Suite 201, Charlotte, NC 28207 Phone: 704-333-1259 Fax: 704-333-0371 | |
Michael Passeri, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1025 Morehead Medical Dr, Suite 600, Charlotte, NC 28204 Phone: 704-355-8816 | |
Jeko Metodiev Madjarov, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1237 Harding Pl, Ste 3100, Charlotte, NC 28204 Phone: 704-373-0212 | |
Jason Shade Burgess, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 Vail Avenue, Ste 320, Charlotte, NC 28207 Phone: 704-333-0741 Fax: 704-333-3356 | |
Toan Thiet Huynh, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-1255 | |
Sara L Turner, NP Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 Blythe Blvd, Charlotte, NC 28203 Phone: 704-512-7562 Fax: 704-512-7576 | |
Robert Gordon Graper, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2915 Coltsgate Rd, Ste 103, Charlotte, NC 28211 Phone: 704-375-7111 Fax: 704-375-0444 |